These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents. Ivanitskaya LP; Makukho LV Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435 [TBL] [Abstract][Full Text] [Related]
8. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors. Tarnowski GS; Cappuccino JG; Schmid FA Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785 [No Abstract] [Full Text] [Related]
9. Potentiation of antitumor drug action by centrophenoxine: specificity. Sladek NE J Pharmacol Exp Ther; 1977 May; 201(2):518-26. PubMed ID: 323465 [TBL] [Abstract][Full Text] [Related]
10. A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models. Emanuel S; Gruninger RH; Fuentes-Pesquera A; Connolly PJ; Seamon JA; Hazel S; Tominovich R; Hollister B; Napier C; D'Andrea MR; Reuman M; Bignan G; Tuman R; Johnson D; Moffatt D; Batchelor M; Foley A; O'Connell J; Allen R; Perry M; Jolliffe L; Middleton SA Mol Pharmacol; 2004 Sep; 66(3):635-47. PubMed ID: 15322256 [TBL] [Abstract][Full Text] [Related]
11. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
12. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Brabec V; Nováková O Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363 [TBL] [Abstract][Full Text] [Related]
13. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors]. Tsuruo T Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181 [TBL] [Abstract][Full Text] [Related]
14. Effect of alkylating antitumor agents on the binding of DNA to protein. Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930 [No Abstract] [Full Text] [Related]
15. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse]. Zeller WJ; Wiessler M; Adzersen KH Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931 [No Abstract] [Full Text] [Related]
17. [The effect of antineoplastic drugs on blood and tumor water-electrolyte balance in mice and rats]. Pashinskiĭ BG Vopr Onkol; 1969; 15(6):65-8. PubMed ID: 5820355 [No Abstract] [Full Text] [Related]
18. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors. Mihich E; Gelzer J Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648 [No Abstract] [Full Text] [Related]
19. Suppression of carcinogenesis by retinoids: interactions with peptide growth factors and their receptors as a key mechanism. Sporn MB; Roberts AB Princess Takamatsu Symp; 1985; 16():149-58. PubMed ID: 3916193 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]